Indeed, following cytokine stimulation, we did observe induction of a cell surface antigen on both primary glioblastoma cell lines and the monocyctic cell line THP-1, which was strongly detected by the commercially available putative IL13Rα2-targeted monoclonal antibody B-D13-PE (Cell Sciences). The gene discussed is IL13RA2; the disease is glioblastoma.